Compare with J.B.Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN PHARMACEUTICALS vs J.B.CHEMICALS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN PHARMACEUTICALS J.B.CHEMICALS SUVEN PHARMACEUTICALS/
J.B.CHEMICALS
 
P/E (TTM) x 43.9 30.8 142.3% View Chart
P/BV x 11.5 7.6 150.3% View Chart
Dividend Yield % 0.4 0.9 40.7%  

Financials

 SUVEN PHARMACEUTICALS   J.B.CHEMICALS
EQUITY SHARE DATA
    SUVEN PHARMACEUTICALS
Mar-21
J.B.CHEMICALS
Mar-21
SUVEN PHARMACEUTICALS/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs5251,318 39.9%   
Low Rs103443 23.2%   
Sales per share (Unadj.) Rs39.7264.3 15.0%  
Earnings per share (Unadj.) Rs12.158.0 20.9%  
Cash flow per share (Unadj.) Rs13.466.9 20.0%  
Dividends per share (Unadj.) Rs2.0016.50 12.1%  
Avg Dividend yield %0.61.9 34.0%  
Book value per share (Unadj.) Rs46.4234.2 19.8%  
Shares outstanding (eoy) m254.5777.28 329.4%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x7.93.3 237.7%   
Avg P/E ratio x25.915.2 170.8%  
P/CF ratio (eoy) x23.513.2 178.6%  
Price / Book Value ratio x6.83.8 180.1%  
Dividend payout %16.528.4 58.0%   
Avg Mkt Cap Rs m79,95368,043 117.5%   
No. of employees `000NANA-   
Total wages/salary Rs m7623,406 22.4%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m10,09720,425 49.4%  
Other income Rs m1421,166 12.2%   
Total revenues Rs m10,24021,591 47.4%   
Gross profit Rs m4,4305,562 79.7%  
Depreciation Rs m316687 46.1%   
Interest Rs m11772 161.1%   
Profit before tax Rs m4,1395,969 69.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,0531,484 71.0%   
Profit after tax Rs m3,0864,485 68.8%  
Gross profit margin %43.927.2 161.1%  
Effective tax rate %25.424.9 102.4%   
Net profit margin %30.622.0 139.2%  
BALANCE SHEET DATA
Current assets Rs m6,66518,939 35.2%   
Current liabilities Rs m3,2156,866 46.8%   
Net working cap to sales %34.259.1 57.8%  
Current ratio x2.12.8 75.2%  
Inventory Days Days200122 163.4%  
Debtors Days Days370695 53.2%  
Net fixed assets Rs m9,0976,786 134.1%   
Share capital Rs m255155 164.7%   
"Free" reserves Rs m11,55417,943 64.4%   
Net worth Rs m11,80818,097 65.2%   
Long term debt Rs m3560-   
Total assets Rs m15,76225,725 61.3%  
Interest coverage x36.583.4 43.7%   
Debt to equity ratio x00-  
Sales to assets ratio x0.60.8 80.7%   
Return on assets %20.317.7 114.7%  
Return on equity %26.124.8 105.5%  
Return on capital %35.033.4 104.8%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m9,9029,082 109.0%   
Fx outflow Rs m1,3691,792 76.4%   
Net fx Rs m8,5337,290 117.1%   
CASH FLOW
From Operations Rs m3,8343,148 121.8%  
From Investments Rs m-3,114-2,307 135.0%  
From Financial Activity Rs m-766-874 87.6%  
Net Cashflow Rs m-45-33 137.7%  

Share Holding

Indian Promoters % 60.0 55.4 108.2%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 13.8 13.2 104.8%  
FIIs % 8.0 5.5 145.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 40.0 44.2 90.4%  
Shareholders   96,532 32,054 301.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN PHARMACEUTICALS With:   SAMRAT PHARMA  GENNEX LAB.  KIMIA BIOSCIENCES  ALCHEMIST LIMITED  PHAARMASIA  



Today's Market

Sensex Gains 460 Points, Nifty Ends Above 18,450; Hindalco and Infosys Rally 5%(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended on a strong note.

Related Views on News

SUVEN PHARMACEUTICALS 2020-21 Annual Report Analysis (Annual Result Update)

Sep 6, 2021 | Updated on Sep 6, 2021

Here's an analysis of the annual report of SUVEN PHARMACEUTICALS for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of SUVEN PHARMACEUTICALS. Also includes updates on the valuation of SUVEN PHARMACEUTICALS.

J.B.CHEMICALS Announces Quarterly Results (3QFY20); Net Profit Up 34.1% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, J.B.CHEMICALS has posted a net profit of Rs 622 m (up 34.1% YoY). Sales on the other hand came in at Rs 4 bn (up 9.3% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (3QFY20); Net Profit Up 34.1% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, J.B.CHEMICALS has posted a net profit of Rs 622 m (up 34.1% YoY). Sales on the other hand came in at Rs 4 bn (up 9.3% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

More Views on News

Most Popular

Is it Time to Switch from Tata Power to NTPC?(Profit Hunter)

Oct 11, 2021

Given the huge run up in Tata Power, does it make sense to switch to NTPC?

This Proxy EV Stock Just got a Power Crisis Boost(Profit Hunter)

Oct 8, 2021

After months of research, I've come across few stocks that excite me far more than the mainstream electric vehicle companies.

Rs 1 Lakh Invested in These Cryptos at the Start of 2021 Became Rs...(Views On News)

Oct 8, 2021

These cryptos would have multiplied investors' wealth by as much as 10,000% in just nine months.

Top 5 'Digital India' Stocks(Views On News)

Oct 6, 2021

These companies are leading the Government's US$1 tn 'Digital India' initiative.

5 Exciting 'Unlisted' Companies and How to Play Them(Views On News)

Oct 7, 2021

Here's how you can invest in some of the most exciting start-ups of the decade.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN PHARMACEUTICALS SHARE PRICE


Oct 18, 2021 (Close)

TRACK SUVEN PHARMACEUTICALS

  • Track your investment in SUVEN PHARMACEUTICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN PHARMACEUTICALS

SUVEN PHARMACEUTICALS - SOURCE NATURAL FOODS COMPARISON

COMPARE SUVEN PHARMACEUTICALS WITH

MARKET STATS